| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.94B | $2.19B | $2.63B |
| YoY Revenue Growth % | -11.4% | -16.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$225.8M | -$60.4M | $166.6M |
| Operating Margin % | -11.6% | -2.8% | 6.3% |
| Net Income (GAAP) | -$355.5M | -$207.8M | -$59.2M |
| EBITDA (Normalized) | -$89.9M | $143.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $189.5M | $367.3M | $553.5M |
| Capital Expenditures (CapEx) | $169.9M | $255.0M | — |
| Free Cash Flow (FCF) | $19.6M | $112.3M | $553.5M |
| FCF Margin % | 1.0% | 5.1% | 21.0% |
| Return on Invested Capital (ROIC %) | -11.4% | -2.5% | — |
| Cash & Short-Term Equivalents | $22.9M | $14.8M | — |
| Total Debt (Short + Long Term) | $875.6M | $944.4M | — |
| Total Stockholders' Equity | $717.5M | $1.01B | — |